Astera Labs, Inc. (ALAB)

Astera Labs Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	198.87	-83.42	-26.26	-58.35
Depreciation & Amortization	4.96	3.15	1.78	0.81
Loss (Gain) From Sale of Investments	-9.69	-8.34	-1.62	-0.53
Stock-Based Compensation	166.88	234.59	10.68	30.24
Other Operating Activities	6.88	3.99	12.38	1.9
Change in Accounts Receivable	-17.52	-30.48	2.39	-6.04
Change in Inventory	-25.12	-19.29	-5.56	-19.36
Change in Accounts Payable	8.08	20.89	-4.26	2.13
Change in Other Net Operating Assets	-69.59	15.59	-2.23	13.3
Operating Cash Flow	263.74	136.68	-12.72	-35.9
Capital Expenditures	-34.3	-34.25	-2.76	-3.87
Investment in Securities	-223.89	-721.91	-15.01	-86.72
Other Investing Activities	-1.91	-1.41	-	-
Investing Cash Flow	-260.11	-757.57	-17.77	-90.59
Issuance of Common Stock	12.79	681.82	1.12	2.12
Repurchase of Common Stock	-1.07	-21.18	-0.21	-0.31
Other Financing Activities	-	-4.8	-1.41	-
Financing Cash Flow	11.73	655.84	-0.5	151.67
Net Cash Flow	15.37	34.95	-30.99	25.18
Free Cash Flow	229.44	102.43	-15.48	-39.77
Free Cash Flow Margin	31.73%	25.85%	-13.37%	-49.79%
Free Cash Flow Per Share	1.32	0.78	-0.42	-1.16
Cash Income Tax Paid	7.79	7.79	2.48	-
Levered Free Cash Flow	115.7	121.1	-7.94	-
Unlevered Free Cash Flow	115.7	121.1	-7.94	-
Change in Working Capital	-104.15	-13.3	-9.68	-9.97

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q